SmartTRAK is reporting that in the 4th quarter of 2024 (Q424) the “skin substitute” market reached almost $2 billion, an increase of 25% compared to the 4th quarter of 2023 (Q423).
Human amniotic products represent the majority of the US market at 76.3%, up from 72.1% in Q423. Three companies: Extremity Care, BioLab Sciences and Legacy Medical, account for over half of the revenue share in the amniotic market. (Contact SmartTRAK to subscribe to detailed market data.)
Dr. Fife is a world renowned wound care physician dedicated to improving patient outcomes through quality driven care. Please visit my blog at CarolineFifeMD.com and my Youtube channel at https://www.youtube.com/c/carolinefifemd/videos
The opinions, comments, and content expressed or implied in my statements are solely my own and do not necessarily reflect the position or views of Intellicure or any of the boards on which I serve.
Interesting – I am sure this rise is because we have more wounds in this country and not because of greed? I would argue that wound care providers are less skilled because these are at their disposal.